Sebastian K King Selected Research

Familial duodenal atresia

1/2020	The Role of Fibroblast Growth Factor 10 Signaling in Duodenal Atresia.
12/2017	Is selective echocardiography in duodenal atresia the future standard of care?
2/2017	Duodeno-duodenostomy or duodeno-jejunostomy for duodenal atresia: is one repair better than the other?

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sebastian K King Research Topics

Disease

7	Constipation 01/2020 - 09/2004
3	Esophageal Atresia 11/2021 - 01/2018
3	Familial duodenal atresia 01/2020 - 02/2017
2	Anorectal Malformations 11/2021 - 12/2005
2	Spinal Dysraphism (Spina Bifida) 04/2017 - 12/2005
1	Inguinal Hernia (Direct Inguinal Hernia) 07/2022
1	Postoperative Pain 07/2022
1	Tracheoesophageal Fistula 11/2021
1	Enuresis 10/2021
1	Heart Diseases (Heart Disease) 04/2021
1	Anastomotic Leak 11/2020
1	Intestinal Atresia 01/2020
1	Pediatric ulcerative colitis 07/2019
1	Wounds and Injuries (Trauma) 05/2018
1	Craniocerebral Trauma (Head Injury) 05/2018
1	Infections 04/2018
1	Empyema 04/2018
1	Heart Arrest (Cardiac Arrest) 04/2018
1	Hemothorax 04/2018
1	Pneumothorax 04/2018
1	Gastroesophageal Reflux (GERD) 01/2018
1	Colitis 06/2017
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 06/2017
1	Precocious Puberty 04/2017
1	Pathologic Constriction (Stenosis) 02/2017
1	Birth Weight (Birth Weights) 02/2017
1	Hypotension (Low Blood Pressure) 12/2016
1	Abscess 12/2016
1	Lactose Intolerance (Intolerance, Lactose) 08/2016
1	Intestinal Pseudo-Obstruction (Intestinal Pseudoobstruction) 01/2016
1	Intussusception 02/2012
1	Multiple Endocrine Neoplasia (Multiple Endocrine Adenomatosis) 02/2006
1	Hyperplasia 01/2006
1	Medullary Carcinoma 01/2006
1	Multiple Endocrine Neoplasia Type 2b (MEN 3) 01/2006
1	Fecal Incontinence 12/2005
1	Nausea 02/2005
1	Vomiting 02/2005

Drug/Important Bio-Agent (IBA)

2	Substance PIBA 07/2011 - 02/2006
2	Neurotransmitter Agents (Neurotransmitter)IBA 02/2006 - 10/2004
1	Opioid Analgesics (Opioids)IBA 07/2022
1	Anesthetics (Anesthetic Agents)IBA 04/2021
1	Type 2 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 2)IBA 01/2020
1	Fibroblast Growth Factor 10IBA 01/2020
1	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 01/2020
1	Calcineurin InhibitorsIBA 07/2019
1	Lactic Acid (Lactate)FDA LinkGeneric 12/2016
1	FructoseIBA 08/2016
1	HydrogenIBA 08/2016
1	SteroidsIBA 02/2012
1	N-(2-acetamido)-2-aminoethanesulfonic acid (ACES)IBA 12/2005
1	AntiemeticsIBA 02/2005

Therapy/Procedure

4	Therapeutics 10/2021 - 09/2004
3	Fundoplication 11/2021 - 01/2018
2	Enema (Enemas) 04/2017 - 12/2005
2	Conservative Treatment 08/2008 - 02/2006
1	Personal Protective Equipment 05/2018
1	Critical Care (Surgical Intensive Care) 05/2018
1	Heart Massage 04/2018
1	Perioperative Care 12/2017
1	Colectomy 06/2017
1	Orchiectomy (Orchidectomy) 04/2017
1	Artificial Respiration (Mechanical Ventilation) 02/2017
1	Jejunostomy 02/2017
1	Duodenostomy 02/2017
1	Laparotomy 02/2017
1	Ileostomy 12/2016
1	Thyroidectomy 01/2006